Go to content
UR Home

Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) – from preclinical studies to a clinical phase II trial

URN to cite this document:
DOI to cite this document:
Specht, Hanno M. ; Ahrens, Norbert ; Blankenstein, Christiane ; Duell, Thomas ; Fietkau, Rainer ; Gaipl, Udo S. ; Günther, Christine ; Gunther, Sophie ; Habl, Gregor ; Hautmann, Hubert ; Hautmann, Matthias ; Huber, Rudolf Maria ; Molls, Michael ; Offner, Robert ; Rödel, Claus ; Rödel, Franz ; Schütz, Martin ; Combs, Stephanie E. ; Multhoff, Gabriele
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 21 Dec 2021 06:40


Heat shock protein 70 (Hsp70) is frequently overexpressed in tumor cells. An unusual cell surface localization could be demonstrated on a large variety of solid tumors including lung, colorectal, breast, squamous cell carcinomas of the head and neck, prostate and pancreatic carcinomas, glioblastomas, sarcomas and hematological malignancies, but not on corresponding normal tissues. A membrane ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons